Literature DB >> 23903189

Histone variant H3.3 maintains a decondensed chromatin state essential for mouse preimplantation development.

Chih-Jen Lin1, Marco Conti, Miguel Ramalho-Santos.   

Abstract

Histone variants can replace canonical histones in the nucleosome and modify chromatin structure and gene expression. The histone variant H3.3 preferentially associates with active chromatin and has been implicated in the regulation of a diverse range of developmental processes. However, the mechanisms by which H3.3 may regulate gene activity are unclear and gene duplication has hampered an analysis of H3.3 function in mouse. Here, we report that the specific knockdown of H3.3 in fertilized mouse zygotes leads to developmental arrest at the morula stage. This phenotype can be rescued by exogenous H3.3 but not by canonical H3.1 mRNA. Loss of H3.3 leads to over-condensation and mis-segregation of chromosomes as early as the two-cell stage, with corresponding high levels of aneuploidy, but does not appear to affect zygotic gene activation at the two-cell stage or lineage gene transcription at the morula stage. H3.3-deficient embryos have significantly reduced levels of markers of open chromatin, such as H3K36me2 and H4K16Ac. Importantly, a mutation in H3.3K36 that disrupts H3K36 methylation (H3.3K36R) does not rescue the H3.3 knockdown (KD) phenotype. In addition, H3.3 KD embryos have increased incorporation of linker H1. Knockdown of Mof (Kat8), an acetyltransferase specific for H4K16, similarly leads to excessive H1 incorporation. Remarkably, pan-H1 RNA interference (RNAi) partially rescues the chromosome condensation of H3.3 KD embryos and allows development to the blastocyst stage. These results reveal that H3.3 mediates a balance between open and condensed chromatin that is crucial for the fidelity of chromosome segregation during early mouse development.

Entities:  

Keywords:  Chromatin condensation; Chromosome segregation; Epigenetics; Histone acetylation; Histone methylation; Histone variant H3.3; Linker histone H1; Mouse preimplantation development

Mesh:

Substances:

Year:  2013        PMID: 23903189      PMCID: PMC3742145          DOI: 10.1242/dev.095513

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  49 in total

1.  PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state.

Authors:  Alejandra Loyola; Tiziana Bonaldi; Danièle Roche; Axel Imhof; Geneviève Almouzni
Journal:  Mol Cell       Date:  2006-10-20       Impact factor: 17.970

2.  PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos.

Authors:  Mareike Puschendorf; Rémi Terranova; Erwin Boutsma; Xiaohong Mao; Kyo-ichi Isono; Urszula Brykczynska; Carolin Kolb; Arie P Otte; Haruhiko Koseki; Stuart H Orkin; Maarten van Lohuizen; Antoine H F M Peters
Journal:  Nat Genet       Date:  2008-03-02       Impact factor: 38.330

3.  Localized H3K36 methylation states define histone H4K16 acetylation during transcriptional elongation in Drosophila.

Authors:  Oliver Bell; Christiane Wirbelauer; Marc Hild; Annette N D Scharf; Michaela Schwaiger; David M MacAlpine; Frédéric Zilbermann; Fred van Leeuwen; Stephen P Bell; Axel Imhof; Dan Garza; Antoine H F M Peters; Dirk Schübeler
Journal:  EMBO J       Date:  2007-11-15       Impact factor: 11.598

4.  30 nm chromatin fibre decompaction requires both H4-K16 acetylation and linker histone eviction.

Authors:  Philip J J Robinson; Woojin An; Andrew Routh; Fabrizio Martino; Lynda Chapman; Robert G Roeder; Daniela Rhodes
Journal:  J Mol Biol       Date:  2008-04-29       Impact factor: 5.469

5.  Maternal BRG1 regulates zygotic genome activation in the mouse.

Authors:  Scott J Bultman; Thomas C Gebuhr; Hua Pan; Petr Svoboda; Richard M Schultz; Terry Magnuson
Journal:  Genes Dev       Date:  2006-07-01       Impact factor: 11.361

6.  Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants.

Authors:  Daniel Paull; Valentina Emmanuele; Keren A Weiss; Nathan Treff; Latoya Stewart; Haiqing Hua; Matthew Zimmer; David J Kahler; Robin S Goland; Scott A Noggle; Robert Prosser; Michio Hirano; Mark V Sauer; Dieter Egli
Journal:  Nature       Date:  2012-12-19       Impact factor: 49.962

7.  Chromatin dynamics during epigenetic reprogramming in the mouse germ line.

Authors:  Katia Ancelin; Tanja Waldmann; Petra Hajkova; Nicolas Lacoste; Ulrike C Lange; Francesca Cesari; Caroline Lee; Genevieve Almouzni; Robert Schneider; M Azim Surani
Journal:  Nature       Date:  2008-03-19       Impact factor: 49.962

8.  The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis.

Authors:  Arun Gupta; T Geraldine Guerin-Peyrou; Girdhar G Sharma; Changwon Park; Manjula Agarwal; Ramesh K Ganju; Shruti Pandita; Kyunghee Choi; Saraswati Sukumar; Raj K Pandita; Thomas Ludwig; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

9.  Mof (MYST1 or KAT8) is essential for progression of embryonic development past the blastocyst stage and required for normal chromatin architecture.

Authors:  Tim Thomas; Mathew P Dixon; Andrew J Kueh; Anne K Voss
Journal:  Mol Cell Biol       Date:  2008-06-09       Impact factor: 4.272

10.  Dynamic distribution of the replacement histone variant H3.3 in the mouse oocyte and preimplantation embryos.

Authors:  Maria-Elena Torres-Padilla; Andrew J Bannister; Paul J Hurd; Tony Kouzarides; Magdalena Zernicka-Goetz
Journal:  Int J Dev Biol       Date:  2006       Impact factor: 2.203

View more
  58 in total

Review 1.  Zygotic genome activation during the maternal-to-zygotic transition.

Authors:  Miler T Lee; Ashley R Bonneau; Antonio J Giraldez
Journal:  Annu Rev Cell Dev Biol       Date:  2014-08-11       Impact factor: 13.827

Review 2.  Mechanisms regulating zygotic genome activation.

Authors:  Katharine N Schulz; Melissa M Harrison
Journal:  Nat Rev Genet       Date:  2019-04       Impact factor: 53.242

3.  Genome editing a mouse locus encoding a variant histone, H3.3B, to report on its expression in live animals.

Authors:  Duancheng Wen; Kyung-Min Noh; Aaron D Goldberg; C David Allis; Zev Rosenwaks; Shahin Rafii; Laura A Banaszynski
Journal:  Genesis       Date:  2014-10-06       Impact factor: 2.487

4.  ATRX contributes to epigenetic asymmetry and silencing of major satellite transcripts in the maternal genome of the mouse embryo.

Authors:  Rabindranath De La Fuente; Claudia Baumann; Maria M Viveiros
Journal:  Development       Date:  2015-04-29       Impact factor: 6.868

5.  KM mutant highlights enhancers in minor ZGA.

Authors:  Yuki Okada; Keisuke Aoshima
Journal:  Cell Cycle       Date:  2015-06-11       Impact factor: 4.534

Review 6.  Point mutations in an epigenetic factor lead to multiple types of bone tumors: role of H3.3 histone variant in bone development and disease.

Authors:  Shigeaki Kato; Takeaki Ishii; Alexander Kouzmenko
Journal:  Bonekey Rep       Date:  2015-07-01

7.  Genetic mosaics and time-lapse imaging identify functions of histone H3.3 residues in mouse oocytes and embryos.

Authors:  Liquan Zhou; Boris Baibakov; Bertram Canagarajah; Bo Xiong; Jurrien Dean
Journal:  Development       Date:  2016-12-19       Impact factor: 6.868

Review 8.  Epigenetic modifications and reprogramming in paternal pronucleus: sperm, preimplantation embryo, and beyond.

Authors:  Yuki Okada; Kosuke Yamaguchi
Journal:  Cell Mol Life Sci       Date:  2017-01-03       Impact factor: 9.261

9.  Integrated Analysis of Quantitative Proteome and Transcriptional Profiles Reveals the Dynamic Function of Maternally Expressed Proteins After Parthenogenetic Activation of Buffalo Oocyte.

Authors:  Fumei Chen; Qiang Fu; Liping Pu; Pengfei Zhang; Yulin Huang; Zhen Hou; Zhuangzhuang Xu; Dongrong Chen; Fengling Huang; Tingxian Deng; Xianwei Liang; Yangqing Lu; Ming Zhang
Journal:  Mol Cell Proteomics       Date:  2018-07-12       Impact factor: 5.911

Review 10.  H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Authors:  J N Nichol; D Dupéré-Richer; T Ezponda; J D Licht; W H Miller
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.